PEPGPepGen Inc.

$435M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$7M

Net Income

-$7M

EPS (Diluted)

$-0.32

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$669,000

Balance Sheet

Total Assets

$144M

Total Liabilities

$11M

Stockholders' Equity

$133M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$29,000	+100.0%
Operating Income	-$7M	-$791,000	-811.6%
Net Income	-$7M	-$797,000	-796.4%

PEPG Q4 2021 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena